U.S. Hospitality Stock News

NasdaqGM:ASST
NasdaqGM:ASSTMedical Equipment

Strive Asset Management (ASST) Q4 US$205.6m Loss Reinforces Bearish Earnings Narratives

Strive Asset Management (ASST) FY 2025 earnings snapshot Strive Asset Management (ASST) has just wrapped up FY 2025 with Q4 total revenue of about US$1.3 million and a loss per share of US$6.17, alongside a net loss excluding extra items of US$205.6 million, setting a stark backdrop for the latest numbers. Over the past year, revenue has moved from roughly US$0.8 million in Q2 2024 to US$1.3 million in Q4 2025, while trailing twelve month EPS shifted from a US$194.99 loss to a US$12.74 loss...
NYSE:MOD
NYSE:MODBuilding

Assessing Modine Manufacturing (MOD) Valuation After Strong Multi‑Period Share Price Momentum

Why Modine Manufacturing is on investors’ radar Modine Manufacturing (MOD) has drawn attention after recent share price swings, including a one-month return of 7% and a gain of 47.5% over the past three months, prompting fresh questions about what is already priced into the stock. See our latest analysis for Modine Manufacturing. At a share price of $200.87, Modine’s recent 4.66% 7 day share price return and 42.65% year to date share price return sit alongside a very large 5 year total...
NYSE:LTH
NYSE:LTHHospitality

What Life Time Group Holdings (LTH)'s Board Exit and New Analyst Coverage Means For Shareholders

On March 9, 2026, Life Time Group Holdings announced that Class I director Alejandro Santo Domingo would resign from its board effective March 31, 2026, while KeyBanc Capital Markets began covering the company with an Overweight rating amid favorable fitness-industry conditions. The coverage initiation underscores Life Time’s positioning as a premium fitness brand benefiting from rising interest in holistic health and wellness across age groups. Next, we’ll examine how KeyBanc’s positive...
NYSE:EPD
NYSE:EPDOil and Gas

Record EBITDA And Robust 2026 FCF Guidance Might Change The Case For Investing In Enterprise Products Partners (EPD)

In recent days, Enterprise Products Partners reported better-than-expected Q4 2025 results, including record quarterly EBITDA of US$2.70 billion, supported by new assets coming online and strong contract coverage across its Permian processing and export terminals. Management’s guidance for US$1.00 billion in free cash flow during 2026, with a large portion earmarked for buybacks and growth projects, highlights how its fee-based midstream model may reinforce cash generation even when...
NYSE:LUV
NYSE:LUVAirlines

Southwest Airlines (LUV) Is Up 5.9% After New Aircraft-Backed Loan And Raised 2026 Outlook

Southwest Airlines recently entered into a new US$500 million senior secured term loan facility maturing in 2029, backed by a pool of aircraft and related assets, while also presenting stronger-than-expected Q4 2025 results and raising its earnings outlook for 2026. This combination of fresh secured funding capacity and upgraded profitability guidance highlights how Southwest is simultaneously shoring up its balance sheet and signaling operating momentum. Next, we’ll examine how Southwest’s...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Is It Too Late To Consider Nebius Group (NBIS) After 364% One Year Surge?

If you are wondering whether Nebius Group's current share price reflects its true worth, the recent trading history gives you plenty to think about. The stock last closed at US$121.52, with returns of 12.5% over 7 days, 24.6% over 30 days, 35.1% year to date, and 364.3% over the past year. This will naturally raise questions about how much of the story is already priced in. Recent attention around Nebius Group has focused on its role in the software sector and how investors are treating high...
NasdaqGS:TITN
NasdaqGS:TITNTrade Distributors

Titan Machinery (TITN) EPS Loss Widens And Tests Bullish Profitability Narratives

Titan Machinery FY 2026 earnings snapshot Titan Machinery (TITN) has wrapped up FY 2026 with fourth quarter revenue of US$641.8 million and a basic EPS loss of US$1.59, while the trailing twelve months show revenue of US$2.4 billion and a basic EPS loss of US$2.38. Over recent quarters the company has seen revenue move from US$759.9 million in Q4 FY 2025 to US$641.8 million in Q4 FY 2026, with quarterly EPS swinging between a small profit of US$0.05 in Q3 FY 2026 and losses in the other...
NYSE:CAL
NYSE:CALSpecialty Retail

Caleres (CAL) Q4 EPS Loss Deepens And Tests Bullish Turnaround Narratives

Caleres (CAL) closed out FY 2026 with fourth quarter revenue of US$695.1 million and a basic EPS loss of US$0.68, while trailing twelve month revenue sat at about US$2.8 billion with a TTM basic EPS loss of US$0.21. Over recent quarters, the company has seen quarterly revenue move between US$614.2 million and US$790.1 million, with basic EPS ranging from a profit of US$0.21 in Q1 2026 to a loss of US$0.68 in Q4. This sets up a story where top line scale is in place but margin pressure is...
NYSE:TRC
NYSE:TRCReal Estate

Tejon Ranch (TRC) Q4 Profitability Rebound Challenges Bearish Earnings Narratives

Tejon Ranch (TRC) has just wrapped up FY 2025 with fourth quarter revenue of US$21.1 million and basic EPS of US$0.06, while the full year on a trailing 12 month basis came in at US$49.6 million of revenue and essentially breakeven EPS around US$0.00. Over recent quarters, the company has seen revenue move from US$8.3 million and basic EPS of a US$0.06 loss in Q2 2025 to US$11.0 million and a US$0.06 loss in Q3 2024, before reaching Q4 2025’s US$21.1 million and US$0.06 EPS. This sets up a...
NYSE:FCN
NYSE:FCNProfessional Services

How Investors May Respond To FTI Consulting (FCN) Expanding Its IQ.AI Legal Workflow Platform

In early March 2026, FTI Consulting’s Technology segment reported growing adoption of its IQ.AI platform among major corporate legal departments and law firms and introduced IQ.AI Studio, a proprietary library of generative AI tasks, models and workflows for complex legal, regulatory and investigation matters across multiple regions. The company highlighted that IQ.AI has already been used on hundreds of matters to compress timelines, reduce manual review workloads and extract structured...
NYSE:BAX
NYSE:BAXMedical Equipment

A Look At Baxter International (BAX) Valuation After CFO Change And Novum LVP Legal Scrutiny

Baxter International (BAX) is back in focus after chief financial officer Joel Grade stepped down. Interim CFO Anita Zielinski is stepping in as legal and governance questions around the Novum LVP infusion pump draw fresh investor attention. See our latest analysis for Baxter International. The share price has retreated sharply to US$16.66, with a 30 day share price return of a 19.67% decline and a 1 year total shareholder return of a 49.50% loss, reflecting fading momentum as investors...
NasdaqGS:PLAB
NasdaqGS:PLABSemiconductor

Photronics (PLAB) Is Up 12.0% After Earnings Beat And Expansion Update - What's Changed

Recently, Photronics reported a strong quarter with revenue increasing 6.1% year on year, surpassing analyst estimates for both sales and earnings per share. Management also emphasized that facility expansion and efforts to broaden the company’s geographic revenue mix are progressing, reflecting how it is adapting its photomask business to a more regionally segmented semiconductor industry. With this earnings beat and reaffirmed progress on facility expansion, we’ll now examine how the...
NYSE:GME
NYSE:GMESpecialty Retail

A Look At GameStop’s (GME) Valuation As Acquisition Talk And Business Overhaul Shape Sentiment

GameStop’s acquisition speculation and transformation plans draw investor focus GameStop (GME) is back in the spotlight as speculation over a possible acquisition of a publicly traded consumer company intersects with CEO Ryan Cohen’s push toward e-commerce, collectibles, and accelerated store closures. See our latest analysis for GameStop. Speculation around a potential acquisition and Cohen’s push to reshape the business have arrived during a choppy period for the stock. The share price has...
NYSE:ACN
NYSE:ACNIT

Accenture (ACN) Margin Slip To 10.6% Tests Bullish Earnings Narratives

Accenture (ACN) has reported Q2 2026 results with revenue of US$18.0b and basic EPS of US$2.96, setting the tone for how its consulting and technology services engine is currently translating into top and bottom line performance. The company has seen quarterly revenue move from US$16.7b in Q2 2025 to US$18.0b in Q2 2026, while basic EPS over the same quarters has shifted from US$2.85 to US$2.96, giving investors a clear read on how sales and earnings are tracking together. With a trailing net...
NYSE:MOV
NYSE:MOVLuxury

Movado Group (MOV) Margin Improvement Tests Bullish Earnings Narratives

Movado Group (MOV) has wrapped up FY 2026 with fourth quarter revenue of US$191.6 million and basic EPS of US$0.55, supported by trailing twelve month revenue of US$671.3 million and EPS of US$1.17, alongside a 44.6% earnings increase over the past year. Over recent quarters, the company has seen revenue move from US$174.7 million and EPS of US$0.30 in Q4 FY 2025 to US$191.6 million and EPS of US$0.55 in Q4 FY 2026. At the same time, trailing net profit margin has shifted from 2.8% to 4%,...
NYSE:IDT
NYSE:IDTTelecom

Assessing IDT (IDT) Valuation As Long Term Returns Contrast With Recent Share Price Softness

Why IDT Is On Investors’ Radar Today IDT (IDT) has drawn fresh attention after recent trading saw mixed short term share performance, with a 1 day gain alongside weaker moves over the week, month and past 3 months. That divergence, combined with its current US$47.79 share price and roughly US$1.18b market cap, is prompting closer scrutiny of how the company’s communications and payments segments are contributing to revenue and earnings. See our latest analysis for IDT. Set against a 1 day...
NasdaqCM:SLNO
NasdaqCM:SLNOBiotechs

Soleno Lawsuit Puts DCCR Safety Disclosures And Growth Story Under Scrutiny

A class action lawsuit has been filed against Soleno Therapeutics (NasdaqCM:SLNO) alleging failures to disclose significant safety concerns in clinical trials for its drug DCCR. The complaint targets the company and certain executives, claiming that undisclosed issues could affect DCCR's commercial prospects and Soleno's reputation. The case focuses on the period around the development and launch preparations of DCCR, Soleno's sole commercial product. Soleno Therapeutics is a biotech...
NasdaqGS:AVAH
NasdaqGS:AVAHHealthcare

Aveanna Healthcare Holdings (AVAH) Return To Profitability Tests Bearish Earnings Narratives

Aveanna Healthcare Holdings (AVAH) delivers full year 2025 results Aveanna Healthcare Holdings (AVAH) has wrapped up FY 2025 with fourth quarter revenue of US$662.5 million, basic EPS of US$0.85 and net income excluding extraordinary items of US$178.8 million. This frames a year where trailing twelve month revenue reached about US$2.4 billion and basic EPS was US$1.11. Over recent periods the company has seen revenue move from US$519.9 million in Q4 FY 2024 to US$662.5 million in Q4 FY 2025,...
NYSE:ORCL
NYSE:ORCLSoftware

A Look At Oracle (ORCL) Valuation After Earnings Beat And Expanding AI Infrastructure Backlog

Oracle (ORCL) has been back in focus after reporting financial results that topped expectations, paired with strong guidance, large AI related contract backlogs, and fresh product launches across healthcare and developer tools. See our latest analysis for Oracle. Despite upbeat earnings and AI headlines, Oracle’s 1 day share price return of 1.71% and 90 day share price return of 18.99% show that recent momentum still lags its earlier surge. At the same time, the 5 year total shareholder...
NYSE:YRD
NYSE:YRDConsumer Finance

Yiren Digital FY 2025 Margin Collapse Challenges High Quality Earnings Narrative

Yiren Digital’s FY 2025 Results Put Margins Under the Microscope Yiren Digital (NYSE:YRD) has just closed out FY 2025 with fourth quarter revenue of C¥957.6 million and a loss per share of C¥10.12, as net income excluding extra items came in at a loss of C¥882.2 million against a C¥2.03 share price. The company has seen quarterly revenue range from C¥1,652.1 million in Q2 2025 to C¥1,452.2 million in Q4 2024. Basic EPS moved from a profit of C¥3.84 in Q4 2024 to a loss in the latest quarter,...
NYSE:BFH
NYSE:BFHConsumer Finance

A Look At Bread Financial Holdings (BFH) Valuation After New Ford Partnership Announcement

Why the Ford partnership matters for Bread Financial Bread Financial Holdings (BFH) is back in focus after Ford Motor Company selected it for a long term co-branded credit card and installment loan program tied directly into Ford’s customer platforms. The market reaction has been constructive, with the stock recently up 3.1% alongside broader gains in financial names, as investors consider what this new Ford relationship could mean for Bread Financial’s card services and lending...
NYSE:NUVB
NYSE:NUVBPharmaceuticals

Is It Time To Reassess Nuvation Bio (NUVB) After Its Recent Share Price Swings?

If you are trying to work out whether Nuvation Bio is attractively priced or not, the recent share performance gives you some useful starting clues. At a last close of US$4.26, the stock has seen a 2.5% decline over the past week and a 27.6% decline over the past month, but is up 117.3% over 1 year and 156.6% over 3 years. Over 5 years, the return sits at a 59.4% decline. This mix of shorter term weakness and longer term strength has put valuation in sharper focus for many investors. With...
NYSE:CF
NYSE:CFChemicals

CF Industries (CF) Faces Pay Governance Fight Amid Blue Ammonia Pivot and Legal Shifts

In March 2026, CF Industries Holdings filed a definitive proxy statement urging shareholders to vote against a proposal to require investor approval for any Named Executive Officer severance package exceeding 2.99 times base salary plus target bonus, while also facing antitrust litigation, progressing a blue ammonia pivot, executing large buybacks, and securing a US$169.50 million legal settlement. This combination of governance tension over executive pay, legal scrutiny, clean-energy...
NYSE:LHX
NYSE:LHXAerospace & Defense

L3Harris Partnership Expands Role In Space Based Missile Threat Tracking

L3Harris Technologies (NYSE:LHX) has agreed to partner with Intuitive Machines’ Lanteris Space Systems on spacecraft platforms for the Space Development Agency’s Tranche 3 Tracking Layer. The program supports real time tracking of missile threats for U.S. defense customers. This partnership expands L3Harris’s role in U.S. missile defense infrastructure, an area not covered in recent company discussions focused on valuation, leadership, and segment realignments. L3Harris operates at the...